PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.64%
Negative revenue growth while AVGO stands at 2.83%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.17%
Negative gross profit growth while AVGO is at 4.82%. Joel Greenblatt would examine cost competitiveness or demand decline.
-13.26%
Negative EBIT growth while AVGO is at 33.22%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-12.91%
Negative operating income growth while AVGO is at 33.22%. Joel Greenblatt would press for urgent turnaround measures.
-20.48%
Negative net income growth while AVGO stands at 160.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-19.48%
Negative EPS growth while AVGO is at 164.15%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-19.74%
Negative diluted EPS growth while AVGO is at 160.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.21%
Share reduction while AVGO is at 0.39%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.19%
Reduced diluted shares while AVGO is at 2.21%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.21%
Dividend growth under 50% of AVGO's 9.45%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-52.12%
Negative OCF growth while AVGO is at 26.25%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-57.63%
Negative FCF growth while AVGO is at 66.15%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
72.62%
10Y revenue/share CAGR under 50% of AVGO's 272.86%. Michael Burry would suspect a lasting competitive disadvantage.
16.03%
5Y revenue/share CAGR under 50% of AVGO's 231.84%. Michael Burry would suspect a significant competitive gap or product weakness.
10.46%
3Y revenue/share CAGR under 50% of AVGO's 179.02%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
89.65%
10Y OCF/share CAGR under 50% of AVGO's 10191.57%. Michael Burry would worry about a persistent underperformance in cash creation.
1.26%
Below 50% of AVGO's 985.76%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
48.44%
3Y OCF/share CAGR under 50% of AVGO's 232.47%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
159.95%
Below 50% of AVGO's 4809.41%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
17.70%
Below 50% of AVGO's 754.86%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
170.91%
3Y net income/share CAGR similar to AVGO's 169.79%. Walter Schloss would attribute it to shared growth factors or demand patterns.
41.87%
Equity/share CAGR of 41.87% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
24.85%
Below 50% of AVGO's 208.89%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2.50%
Below 50% of AVGO's 70.87%. Michael Burry suspects a serious short-term disadvantage in building book value.
1248.38%
Dividend/share CAGR of 1248.38% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
182.07%
Dividend/share CAGR of 182.07% while AVGO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
99.80%
3Y dividend/share CAGR at 50-75% of AVGO's 194.86%. Martin Whitman might see a weaker short-term approach to distributing cash.
11.88%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
3.36%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.12%
Negative asset growth while AVGO invests at 1.96%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.01%
Under 50% of AVGO's 11.43%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-0.09%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
8.68%
R&D growth drastically higher vs. AVGO's 0.43%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
2.33%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.